REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/04/2025
Voltar para busca
Dado oficial do USPTO
PD NEUROTECHNOLOGY MEDICAL SOLUTIONS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
08/04/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 10, 41, 44
Data de depósito
23/05/2018
Data de registro
07/04/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/04/2020
Última transação
08/04/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
GB
Examinador
EUBANK, REBECCA
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the wording "PD NEUROTECHNOLOGY" stacked over the wording "MEDICAL SOLUTIONS" in stylized font all under a design consisting of three shaded diamonds.
Titulares e representantes
Titulares
PD NEUROTECHNOLOGY LTD
Representantes
M. Scott Alprin Alprin Law Offices, P.C.
Classificação técnica
Classes Nice
Classe 9Classe 10Classe 41Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Mobile applications for the monitoring and treatment of movement disorders and related diseases and neurological conditionsincluding Parkinson's diseasesclerosisAlzheimer'ssleep disordersinsomnia and stroke; wearable motion sensors and computer peripherals in the nature of activity trackers; wearable wireless communication devices for data storage and transmission; downloadable mobile applications for operatingaccessing data from wearable computer devices; computer application software for operating and accessinganalyzing and processing data from wearable computer devices; wearable devices in the nature of motion sensors for sensing and monitoring movement; computer hardwaresoftware and application software for storing and accessing personalpatientcareclinicalmedical and healthcare data; Software for creating electronic diaries and logs relating to personalpatientcareclinicalmedical and healthcare data; computer software and application software for accessing informationtracking and monitoring patient data relating to the medical conditions and treatments; computer software and application software for personalpatientcareclinicalmedical and healthcare data recordingcollectionprocessingreportinganalysisintegrationorganisationcompilationamalgamationevaluation and management; computer software and application software for accessing informationtracking and monitoring patient data to support medical decision making and medical expert systems; computer hardware and software for accessing informationtracking and monitoring patient data relating to sports performancemovementtraining and conditioning; computer software and application software for accessing informationtracking and monitoring patient data relating to medicine and healthcare; Electronic computer databases and database systems in the field of medicine and healthcare recorded on computer media; Software applications for managing computer databases systems in the field of personalpatientcareclinicalmedical and healthcare data; computer software and application software for creatingorganisingsearching and updating databases of personalpatientcareclinicalmedical and healthcare datainformation and records; Sensors for scientific use to be worn by a human to collect human biometric data; none of the aforesaid goods relating to in-vitro diagnostics or to human papilloma virus
Classe 10
Medical apparatus and instruments for monitoring vital signs; medical wearable devices for the monitoring and treatment of movement disorders and related diseases and neurological conditionsParkinson's disease; electronic monitoring devices for monitoring vital signs for medical use; medical instruments for recording heart activity; Sensory apparatus for medical usephysical motion sensors that monitor the physical movements of a patient wearing or carrying the device; electronic monitoring devices in the nature of patient physical movement monitors for medical use in monitoring and treating patients; patient monitoring instruments for monitoring physical movement of a patient wearing or carrying the device; apparatus and instruments for use in monitoring and treatment of movement disorders and related diseases and neurological conditionsParkinson's disease; none of the aforesaid goods relating to in-vitro diagnostics or to human papilloma virus
Classe 41
Medical training and education services in the nature of seminars and video training in the field of treatment of Parkinson's disease; advisoryinformationconsultancy services relating to physician and caregiver training; none of the aforesaid goods relating to in-vitro diagnostics or to human papilloma virus
Classe 44
Medical and health care services; medical services relating to wearable devices and mobile applications for the monitoring and treatment of movement disorders and related diseases and neurological conditionsincluding Parkinson's disease; Medical services in the nature of monitoring patients; informationadvisory and consultancy services relating to medicine and healthcare; Medical informationadvisory and consultancy services relating to longevity and quality of life for patients with Parkinson's disease; Medical diagnosis and treatment of Parkinson's disease; medical analysis and preparation of reports relating to the treatment of Parkinson's disease for treatment purposes; Medical services in the nature of assessment and monitoring of patients; healthcare services relating to personal caresupport and welfare; Providing medical information to patientsmedical professionalsmedical caregivers in the nature of preparing data and reports in the field of treating Parkinson's disease; medical testing services relating to the diagnosis and treatment of Parkinson's disease; Medical informationadvisory and consultancy services relating to Parkinson's disease; none of the aforesaid goods relating to in-vitro diagnostics or to human papilloma virus
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/09/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
13/08/2020
FIMP
FINAL DISPOSITION PROCESSED
13/08/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/07/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
07/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/01/2020
PUBO
PUBLISHED FOR OPPOSITION
21/01/2020
GPNX
NOTIFICATION PROCESSED BY IB
17/01/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/01/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/01/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2020
ALIE
ASSIGNED TO LIE
16/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/12/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
10/12/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/12/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
10/12/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/12/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
28/06/2019
GNFR
FINAL REFUSAL E-MAILED
28/06/2019
CNFR
FINAL REFUSAL WRITTEN
28/06/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/06/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/06/2019
RFNT
REFUSAL PROCESSED BY IB
21/12/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/12/2018
RFRR
REFUSAL PROCESSED BY MPU
06/12/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/11/2018
CNRT
NON-FINAL ACTION WRITTEN
19/11/2018
MAFR
APPLICATION FILING RECEIPT MAILED
13/11/2018
DOCK
ASSIGNED TO EXAMINER
09/11/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/11/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/11/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PD NEUROTECHNOLOGY MEDICAL SOLUTIONS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.